CIK 0001217234
- Large accelerated filer
CareDx, Inc.
Sign in to watch- Ticker
- CDNA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943316839
- Phone
- +1 415-287-2300
- Business address
- 8000 MARINA BLVD, 4TH FLOOR, BRISBANE, CA, 94005
- Former names
- XDx, Inc., EXPRESSION DIAGNOSTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,412,526
- in 4 filings, $6.4M under 10b5-1 plans
Net −$6,412,526. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-14 | King Sasha Chief Commercial Officer | Exercise or conversion | +1,250 | $6.31 | $8K | 52,306 |
| 2021-01-14 | King Sasha Chief Commercial Officer | Exercise or conversion | +1,000 | $27.17 | $27K | 53,306 |
| 2021-01-14 | King Sasha Chief Commercial Officer | Sale | −700 | $85.24 | $60K | 52,606 |
| 2021-01-14 | King Sasha Chief Commercial Officer | Sale | −1,400 | $86.46 | $121K | 51,206 |
| 2021-01-14 | King Sasha Chief Commercial Officer | Sale | −2,601 | $87.56 | $228K | 48,605 |
| 2021-01-14 | King Sasha Chief Commercial Officer | Sale | −5,174 | $88.16 | $456K | 43,431 |
| 2021-01-14 | King Sasha Chief Commercial Officer | Exercise or conversion · Employee Stock Option (right to buy) | −833 | 1,042 | ||
| 2021-01-14 | King Sasha Chief Commercial Officer | Exercise or conversion · Employee Stock Option (right to buy) | −2,500 | 8,333 | ||
| 2021-01-14 | King Sasha Chief Commercial Officer | Exercise or conversion · Employee Stock Option (right to buy) | −417 | 1,111 | ||
| 2021-01-14 | King Sasha Chief Commercial Officer | Exercise or conversion · Employee Stock Option (right to buy) | −750 | 750 | ||
| 2021-01-14 | King Sasha Chief Commercial Officer | Exercise or conversion · Employee Stock Option (right to buy) | −3,125 | 17,708 | ||
| 2021-01-14 | King Sasha Chief Commercial Officer | Exercise or conversion · Employee Stock Option (right to buy) | −1,250 | 5,417 | ||
| 2021-01-14 | King Sasha Chief Commercial Officer | Exercise or conversion · Employee Stock Option (right to buy) | −1,000 | 8,333 | ||
| 2021-01-06 | Cohen Fred E Director | Exercise or conversion | +15,000 | $14.74 | $221K | 105,893 |
| 2021-01-06 | Cohen Fred E Director | Exercise or conversion · Stock Option (right to buy) | −15,000 | 0 | ||
| 2021-01-05 | Maag Peter Executive Chair | Exercise or conversion | +10,000 | $6.31 | $63K | 431,974 |
| 2021-01-05 | Maag Peter Executive Chair | Sale | −7,174 | $71.75 | $515K | 424,800 |
| 2021-01-05 | Maag Peter Executive Chair | Sale | −2,826 | $72.36 | $205K | 421,974 |
| 2021-01-05 | Maag Peter Executive Chair | Exercise or conversion · Employee Stock Option (right to buy) | −10,000 | 20,140 | ||
| 2021-01-04 | SNYDERMAN RALPH Director | Grant or award | +215 | 84,672 |
Page 41 of 44 · 865 trades